Skip to main content.

Valley Fever Symposium

Federal Agencies Get Involved

Fellowship Story Showcase

Valley Fever Symposium

For Shane Hoover, treatment at Kern Medical Center for valley fever can take up a good portion of the day. Not too long ago he thought he was dying from valley fever. His treatment has helped him gain weight and strength. Henry Barrios/The Bakersfield Californian

Reporting on Health Collaborative
Sunday, September 22, 2013

BY RACHEL COOK, Reporting on Health Collaborative

In his mid-20s, Shane Hoover started planning for his death.

Hoover was diagnosed with valley fever, which is caused by inhaling fungal spores that grow in the soil, in 2010. He took medications for a while that kept it at bay. But he says he could not afford to keep paying for the drugs and, when he stopped, the disease intensified.

“He’d say, ‘I feel my body shutting down. I feel like it’s just a war inside of me that I can’t win,’” his mother, Kathleen Birks, said. “Our conversations became, ‘What do you want me to do with you when you die?’”

For decades, valley fever patients and their families have fought what felt like an unwinnable war, and many have lost. The disease, also known as coccidioidomycosis, does not get enough attention or funding to create better awareness, diagnosis, treatments and a vaccine to prevent it.

But next week, the disease and the California valley hit hardest by it will receive unprecedented attention in a two-day valley fever symposium led by U.S. Rep. Kevin McCarthy, R-Bakersfield. Rarely do the leaders of the U.S. Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) — two of the most powerful health institutions in the world — join the stage. Both will speak and listen to the community, raising hopes that the growing momentum around the disease will finally shake loose the private and public money to make progress fighting valley fever.

“To my knowledge, it’s the first time that we’ve had all of these big names together and I think the timing is right,” said state Sen. Jean Fuller, R-Bakersfield, who will moderate a panel on California public health policy.

The event was prompted by the “Just One Breath” series about the disease published by The Californian and other outlets that make up a consortium known as the Reporting on Health Collaborative.

“It's a rare opportunity to have some of the most important minds and decision makers in the world of public health (together) focused on one disease,” said Dr. Benjamin Park, who leads the epidemiology team in the CDC’s Mycotic Diseases Branch.


The symposium is open to the public and begins Monday afternoon with the reception for survivors at the Kern County Public Health Services Department. The reception will be followed by a forum with McCarthy, CDC director Dr. Thomas Frieden and NIH director Dr. Francis Collins.

“It’s very important that the survivors come out and show that we’re fighting,” said Jessica Einstein, director of communications for the Valley Fever Americas Foundation.

The symposium will continue Tuesday with physicians, public health officials and politicians sharing what they know about valley fever at Cal State Bakersfield.

Dr. Paul Krogstad, a professor of pediatrics and pharmacology at the David Geffen School of Medicine at UCLA, will speak about the symptoms and best treatments for valley fever in children. Children are incredibly vulnerable to developing serious cases of the disease, Krogstad said.

“Prevention and cure for those already affected are goals that we should set for ourselves,” Krogstad said. “If you have meningitis (caused by valley fever), you will likely be on lifelong medication.”


The symposium arrives as valley fever is riding a swell of political attention and media coverage. McCarthy has started a congressional valley fever task force and urged the U.S. Food and Drug Administration to waive a fee in order to make a skin test for the disease available.

Dr. Michael MacLean, Kings County health officer, said the year-long “Just One Breath” reporting project did “a remarkable amount” to draw attention to valley fever. The series chronicled the rise in valley fever cases, the toll the disease takes on people, and the lack of attention to the deadly illness.

“(The symposium is) more than rare; I think it’s unprecedented,” MacLean said. “I’m not sure this would have happened without the awareness (the series) raised.”

The presenters said meaningful cooperation among researchers, policymakers, physicians and communities is needed to take on valley fever long-term. They talked about the way similar coalitions rallied to advance the science behind diabetes, HIV/AIDS and other conditions.

“It's one disease and it should be a collaboration of anybody who wants to help solve it. This forum in Bakersfield is an opportunity to forge that collaboration,” said Dr. John Galgiani, director of the Valley Fever Center for Excellence and a professor at the University of Arizona.

Kirt Emery, Kern County epidemiologist, has seen interest in valley fever spike when cases peaked in first the early 90s and again in recent years. This time, he hopes the disease will not fade from the limelight until the next epidemic.

“What I’m hoping is that we can sustain the excitement, the activity, and really do something that matters,” he said.


For Hoover, the symposium is a chance to encourage other valley fever survivors who feel like giving up.

Hoover joked with his mother last Wednesday afternoon following one of three intravenous treatments of antifungal medication that he undergoes every week. Now his mother is helping him pay for his medications.

“I’m better at it than I thought I was gonna be,” he laughed.

But the medical bills continue to pile up. Hoover lives in a trailer in the front of his mother’s home. She and her husband have shelved remodeling plans to cover the costs.

“He’s still deathly ill. The doctors still tell us that the battle isn’t even over yet,” Birks said “They don’t even know if it will end.”

Birks hopes that by going to the survivors reception with Hoover, she can push the cause forward, closer to a vaccine that could protect her 16 grandchildren.

“Even if you’ve lost someone to valley fever, you need to (attend the reception),” Birks said. “You need to stand up for what’s ours and what’s ours are these children and our children’s children. This is life and death.”


Monday — Local Awareness

Kern County Department of Public Health Services, Hans Einstein Education Center, 1800 Mount Vernon Ave.

4:30 to 5:30 p.m.: Valley Fever Survivors Reception.

5:30 to 7 p.m.: Public forum with Rep. Kevin McCarthy, R- Bakersfield, Centers for Disease Control and Prevention Director Dr. Thomas Frieden, and National Institutes of Health Director Dr. Francis Collins. The public forum will be live streamed on

Tuesday — Fighting Valley Fever — A Call to Action

Cal State Bakersfield Multi-Purpose Room in the Student Union.

7:30 a.m.: Check in.

7:45 a.m.: Opening remarks.

State of the Science Presentations

8 to 10 a.m.: A Call to Action, presentations by Kern County researchers and others

10 a.m. to 12:30 p.m.: Role of CDC and NIH, panels lead by Frieden and Collins

No-host lunch

1 to 1:45 p.m.: The Congressional Valley Fever Task Force, panel including McCarthy, Rep. David Valadao, R-Hanford, and Rep. David Schweikert, R-Ariz.

2 to 2:45 p.m.: California Public Policy and Challenges, featuring politicians and public health officials


3 to 3:45 p.m.: Susceptible Populations and Valley Fever, featuring pediatricians

4 to 4:45 p.m.: Pets/Animals and Valley Fever, featuring veterinarians

For more information, call 661-327-3611 or email RSVP not required, all sessions are open to the public.

Parking for Monday’s event will be available in the lot in front of the Kern County Department of Public Health Services building. The Hans Einstein Education Center is on the first floor.

Reserved parking for Tuesday’s program at CSUB will be available in Lots L and K. The space for Tuesday’s event can hold 200 people.

Source: Vince Fong, district director for Rep. Kevin McCarthy; Kern County Department of Public Health Services; Cal State Bakersfield.

About This Series

This project results from an innovative reporting venture – the Center for Health Journalism Collaborative – which currently involves the Bakersfield Californian, Radio Bilingüe in Fresno, Valley Public Radio in Fresno and Bakersfield, Vida en el Valle in Fresno, Hanford Sentinel, the Voice of OC in Santa Ana, the Arizona Daily Star in Tucson, La Estrella de Tucsón and the Center for Health Journalism. The collaborative is an initiative of the Center for Health Journalism at the University of Southern California’s Annenberg School for Communication and Journalism.


A Fever in the Dust

Although still unknown outside of the American west, valley fever is a severe fungal infection — and its territory may expand as the climate warms.

In 2018, Governor Jerry Brown Allocated $8 million to Cocci Research And Awareness. How Has It Been Spent?

In his final 2018-2019 budget former California Gov. Jerry Brown allocated $8 million in state funding toward combating valley fever, split evenly between the University of California system and the new Valley Fever Institute at Kern Medical in Bakersfield. Here’s how that money’s been spent.

Following Funding Boosts, Momentum Builds Around Valley Fever Research

Researchers have been trying to understand valley fever for decades, but the playing field remained small until recently.

‘Eureka moment’ in valley fever case paves way for new research, treatment options

UCLA's Dr. Manish Butte still remembers the day almost two years ago when he met a young boy who could barely walk or talk and needed a feeding tube to eat. He was suffering from a life-threatening case of valley fever.

Valley fever medication poses added risk for pregnant women

Research suggests an alarming link between a common drug used for valley fever and birth defects. The disease also tends to be more severe in pregnant women.

Legislation caps momentous year in battle against valley fever

Recently signed legislation capped a big year for efforts to combat a regional disease long overlooked by lawmakers.

For valley fever survivors, a growing need: wigs

The antifungal drugs used to treat valley fever can cause hair loss. With the number of valley fever cases on the rise, a wig shop in Bakersfield, Calif., is helping women feel better about themselves.

California budget boosts funding for valley fever

The budget includes $8 million for research and outreach into the disease, caused by inhaling spores that grow in arid soil.